Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models.
Isabel Quiros-GonzalezMichal R TomaszewskiMonika A GolinskaEmma BrownLaura Ansel-BollepalliLina HackerDominique-Laurent CouturierRosa M SainzSarah Elizabeth BohndiekPublished in: Cancer research (2022)
Photoacoustic assessment of tumor oxygenation is a noninvasive early indicator of response to bevacizumab therapy, clearly distinguishing between control, responding, and resistant tumors within just a few weeks of treatment.